| Dr Richard Keeler, MD | |
|
22635 Ne Marketplace Dr., Suite #120, Redmond, WA 98053 | |
| (425) 898-7408 | |
| (425) 898-7409 |
| Full Name | Dr Richard Keeler |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 22635 Ne Marketplace Dr., Redmond, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063649705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A107763 (California) | Secondary |
| 208000000X | Pediatrics | MD 60212424 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Keeler, MD 22635 Ne Marketplace Dr., Suite #120, Redmond, WA 98053 Ph: (425) 460-5600 | Dr Richard Keeler, MD 22635 Ne Marketplace Dr., Suite #120, Redmond, WA 98053 Ph: (425) 898-7408 |
News Archive
Researchers may be "excyted" to learn that osteocyte cultures are headed to the International Space Station this spring for the first time. With their delivery on the next SpaceX commercial resupply services mission this month, the Osteocytes and mechano-transduction (Osteo-4) investigation team will analyze the effects of microgravity on this type of bone cell.
New research published in this month's edition of United European Gastroenterology journal suggests that supplementation with vitamin D may impact on the intestinal barrier dysfunction associated with Crohn's disease, and could have a role in the treatment of the condition.
Research led by the Liverpool School of Tropical Medicine has identified the genetic basis for resistance to commonly-used insecticides in one of the major malaria-carrying mosquitoes in Africa.
Synta Pharmaceuticals Corp. announced today that interim results from the Phase 2b/3 GALAXY trial will be presented at the Chemotherapy Foundation Symposium in New York City on Friday, November 9 during the 11:45 a.m. session on new agents for lung cancer. Presenting this data at the conference will be Dr. Suresh Ramalingham, Professor, Hematology & Medical Oncology, and Director, Translational Thoracic Malignancies Program, of the Winship Cancer Institute of Emory University.
Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.
› Verified 2 days ago
Robert C Atkins, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 | |
Ruth Crosby, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7530 164th Ave. Ne, Suite #a215, Redmond, WA 98052 Phone: 425-885-9292 Fax: 425-885-9106 | |
Mona Chhabra, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7530 164th Ave. Ne, Suite #a215, Redmond, WA 98052 Phone: 425-885-9292 Fax: 425-885-9106 | |
Lorena Luoh-wen Shih, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7530 164th Ave. Ne, Suite #a215, Redmond, WA 98052 Phone: 425-885-9292 Fax: 425-885-9106 | |
Dr. Robert Lu, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7530 164th Ave. Ne, Suite #a215, Redmond, WA 98052 Phone: 425-885-9292 Fax: 425-885-9106 | |
Dr. Elizabeth Grace Altomare, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7530 164th Ave Ne Ste A215, Redmond, WA 98052 Phone: 425-885-9292 |